Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does statin therapy improve short-term clinical outcomes in acute coronary syndromes?

Nature Clinical Practice Cardiovascular Medicine volume 3, pages 592–593 (2006)Cite this article

boxed-textBriel M et al. (2006) Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials. JAMA 295: 2046–2056

In acute coronary syndromes statin therapy should be started without delay

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cholesterol Treatment Trialists' (CTT) Collaborators (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet 366: 1267–1278

  2. Colhoun H et al. (2005) Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS). Diabetologia 48: 2482–2485

    Article  CAS  Google Scholar 

  3. Durrington P et al. (2006) Apolipoproteins as predictors of cardiovascular risk in the Collaborative AtoRvastatin Diabetes Study (CARDS) Atherosclerosis Suppl 7 (3): 37

    Article  Google Scholar 

  4. Ridker PM (2003) Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. Circulation 108: 2292–2297

    Article  Google Scholar 

  5. Schwartz GG et al. (2001) Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomised controlled trial. JAMA 285: 1711–1718

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Carol Lovegrove, Freelance Medical Writer.

Author information

Authors and Affiliations

  1. Professor of Medicine in the Division of Cardiovascular and Endocrine Science, University of Manchester and Consultant Physician at the Manchester Royal Infirmary, Manchester, UK

    Paul Durrington

Authors
  1. Paul Durrington
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Durrington.

Ethics declarations

Competing interests

Paul Durrington has received fees for lectures and advice, and research funding from pharmaceutical companies manufacturing lipid-lowering drugs. He has no stock or other financial interests in such companies.

Supplementary information

Supplementary Figure 1

A graph showing the hazard rate ratio for cardiovascular disease events in the Cholesterol Treatment Trialists' Collaborators meta-analysis after random allocation to statin or to control treatment.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Durrington, P. Does statin therapy improve short-term clinical outcomes in acute coronary syndromes?. Nat Rev Cardiol 3, 592–593 (2006). https://doi.org/10.1038/ncpcardio0687

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0687

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing